Literature DB >> 11391151

Does stool collection method affect outcomes in immunochemical fecal occult blood testing?

H Nakama1, B Zhang, A S Abdul Fattah, N Kamijo.   

Abstract

PURPOSE: This paper compares the positive predictive value of an immunochemical fecal occult blood test for colorectal neoplasms between the stool specimens obtained during the digital rectal examination and those obtained during the routine screening.
METHODS: In a medical check-up, 1,688 subjects received both an immunochemical fecal occult blood test and a colonoscopy. Fecal occult blood was tested by two methods: digital rectal examination and routine screening. The positivity rate of an immunochemical fecal occult blood test and the positive predictive value for colorectal cancer and large adenomatous polyp were determined by these two methods.
RESULTS: The positivity rate and the positive predictive value were 5.4 percent and 19.8 percent (4.4 percent for cancer and 15.4 percent for adenomatous polyp) in the digital rectal examination method and 3.5 percent and 27.1 percent (6.8 percent for cancer and 20.3 percent for adenomatous polyp) in the routine screening method, respectively. These figures indicate a significant difference in the positivity rate (P < 0.01) and the positive predictive value (P < 0.05) between these two methods.
CONCLUSIONS: These findings indicate that the stool obtained by routine screening has a better positive predictive value than stool collected during the digital rectal examination.

Entities:  

Mesh:

Year:  2001        PMID: 11391151     DOI: 10.1007/bf02234712

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  5 in total

Review 1.  FIT testing: an overview.

Authors:  Lukejohn W Day; Taft Bhuket; James Allison
Journal:  Curr Gastroenterol Rep       Date:  2013-11

Review 2.  Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling.

Authors:  Tobias Niedermaier; Korbinian Weigl; Michael Hoffmeister; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2017-06-30       Impact factor: 8.082

Review 3.  Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas J Robertson; Jeffrey K Lee; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; David Lieberman; Theodore R Levin; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2016-10-18       Impact factor: 10.864

4.  Stool DNA and occult blood testing for screen detection of colorectal neoplasia.

Authors:  David A Ahlquist; Daniel J Sargent; Charles L Loprinzi; Theodore R Levin; Douglas K Rex; Dennis J Ahnen; Kandice Knigge; M Peter Lance; Lawrence J Burgart; Stanley R Hamilton; James E Allison; Michael J Lawson; Mary E Devens; Jonathan J Harrington; Shauna L Hillman
Journal:  Ann Intern Med       Date:  2008-10-07       Impact factor: 25.391

5.  Patients and Providers Are Amenable to Fecal Immunochemical Testing by Digital Rectal Exam.

Authors:  Harini Naidu; Brian C Jacobson
Journal:  J Patient Exp       Date:  2018-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.